NCT00433589 2022-11-17
MINDACT
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
Clinical Trials
5 trialsNCT00004205 2017-12-12
BIG 1-98
ETOP IBCSG Partners Foundation
Phase 3 Completed
NCT00044291 2015-07-31
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Intarcia Therapeutics
Phase 3 Completed
NCT00267553 2007-09-10
Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer
Intarcia Therapeutics
Phase 3 Terminated
NCT00097344 2007-08-23
The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Intarcia Therapeutics
Phase 3 Terminated